To view this email as a web page, click here.
 
CLINICAL UPDATES
 
Holmium, thulium lasers show similar ablative effect on stones
The super-pulse thulium fiber laser confers an advantage at maximal dusting settings, according to a recent study.
Get the data
 
FDA approves new indication for advanced prostate Ca treatment
The FDA has approved apalutamide (Erleada) for the treatment of patients with metastatic castration-sensitive prostate cancer, a new indication for the next-generation androgen receptor inhibitor.
Learn more
 
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
MORE FROM UROLOGY TIMES
 
Uro Pipeline: Hyperoxaluria agent shows substantial treatment effect
Cystoscopy overuse common in surveillance of low-risk bladder Ca
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.